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Methylmercury (MeHg) is a global environmental problem and is listed by the International Program of Chemical Safety as one of the six most dan-
gerous chemicals in the world's environment. Human exposure to MeHg primarily occurs through the consumption of contaminated food such as
fish, although catastrophic exposures due to industrial pollution have occurred. The fetus is particularly sensitive to MeHg exposure and adverse
effects on infant development have been associated with levels of exposure that result in few, if any, signs of maternal clinical illness or toxicity.
High levels of prenatal exposure in humans result in neurobehavioral effects such as cerebral palsy and severe mental retardation. Prenatal exposure
to MeHg in communities with chronic low-level exposure is related to decreased birthweight and early sensorimotor dysfunction such as delayed
onset of walking. Neurobehavioral alterations have also been documented in studies with nonhuman primates and rodents. Available information on
the developmental neurotoxic effects of MeHg, particularly the neurobehavioral effects, indicates that the fetus and infant are more sensitive to
adverse effects of MeHg. It is therefore recommended that pregnant women and women of childbearing age be strongly advised to limit their expo-
sure to potential sources of MeHg. Based on results from human and animal studies on the developmental neurotoxic effects of methylmercury,
the accepted reference dose should be lowered to 0.025 to 0.06 MeHg pg/kg/day. Continued research on the neurotoxic effects associated with
low level developmental exposure is needed. - Environ Health Perspect 103(Suppl 6):135-142 (1995)
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Introduction
It is well established that prenatal exposure
to certain toxic chemicals can have pro-
found and irreversible effects on the physi-
cal and mental development of children.
Of agents known to act as toxicants, those
that cause central nervous system damage
(neurotoxicants) constitute a particularly
significant public health hazard. While
episodes ofhigh-dose neurotoxicant expo-
sure to children have shown clear evidence
of neurological disorders, the more subtle
action of moderate to low-dose neurotoxi-
cant exposure on important parameters of
behavioral development is increasingly evi-
dent (1-3). Laboratory-based research and
documented incidents of human exposure
to neurotoxicants such as lead, alcohol, and
methylmercury (MeHg) point to a contin-
uum ofeffects in exposed children ranging
This paper was presented at the Symposium on
Preventing Child Exposures to Environmental
Hazards: Research and Policy Issues held 18-19
March 1994 in Washington, DC. Manuscript received:
December 5, 1994; accepted: May 15, 1995.
The authors thank Deborah C. Rice, Thomas M.
Burbacher, and Rafael Ponce for discussions and
comments on this manuscript. Preparation of this
manuscript was supported in part by National
Institutes of Health grant ES03745.
Address correspondence to Dr. Steven G. Gilbert,
Department of Environmental Health, XD-41,
University of Washington, Seattle, WA 98195.
Telephone (206) 543-9780. Fax (206) 685-4696. E-
mail sgg~u.washington.edu
from subtle behavioral changes to frank
expression of neurological damage and
death. In general, the long-term conse-
quences ofdevelopmental exposure to neu-
rotoxicants are only now beginning to
receive scientific attention.
Although there are a number ofimpor-
tant neurotoxicants, this article focuses on
the effects of developmental exposure to
MeHg, a prevalent environmental contam-
inant. The serious public health concerns
associated with MeHg exposure have
resulted in world-wide attention, research,
and review (4-14). The aim ofthis article
is to provide an updated overview of the
developmental effects ofMeHg exposure,
reexamine currently recommended expo-
sure guidelines, and highlight future
research needs.
In recognition ofthe adverse effects of
MeHg exposure, state and federal govern-
ment agencies and international agencies
have developed recommendations to limit
MeHg exposure. For example, the U.S.
Food and Drug Administration (U.S.
FDA) recommends a limit of 1 pg/g (1
ppm) mercury in the edible portion offish.
The U.S. Environmental Protection
Agency (U.S. EPA) has established a refer-
ence dose (RfD) for methylmercury at 0.3
pg/kg/day, which is equivalent to con-
sumption of 19 pg per day ofMeHg for a
62-kg woman (15). The RfD is defined as
an estimate ofa daily exposure to a human
population that is likely to be without an
appreciable risk of deleterious effects dur-
ing a life time and is meant to include sen-
sitive subgroups. The RfD typically is
arrived at through standard risk assessment
procedures that include a careful evaluation
ofstudy results, determination of the low-
est observed adverse effect level (LOAEL)
dose, and division of the LOAEL by an
appropriate uncertainty factor to yield a
RfD. The World Health Organization
(WHO) does not use the RfD nomencla-
ture but developed a similar recommenda-
tion that is equivalent to 0.47 pg/kg/day in
adults (16) while noting that pregnant
women, nursing mothers, and their infants
are likely to be at greater risk. A recent
reevaluation of the RfD for MeHg was
done by Stern (14), who concluded that
the RfD should be lowered to 0.07
pg/kg/day based on human and animal
studies on developmental effects ofMeHg.
Upon review ofthe human and animal lit-
erature, the authors of the current review
reached a similar conclusion.
Mercury Contamination
Methylmercury Exposure
Mercury is generally released into the envi-
ronment in an inorganic form by both nat-
ural and anthropogenic sources (4,11,16,
17). Natural sources of mercury include
emissions from volcanoes, degassing of the
earth's crust, and evaporation from water.
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Artificial sources ofmercury include indus-
trial pollution, burning offossil fuels, min-
ing, refuse incineration, and cremation.
Natural emissions of mercury into the
atmosphere have been estimated to range
from 2700 to 6000 metric tons per year,
while world wide mining ofmercury is esti-
mated to yield 10,000 tons per year (4). It
is estimated that human activities result in
the release of3000 tons peryear ofmercury.
A significant source ofenvironmental mer-
cury contamination is gold mining in coun-
tries such as in Brazil (18,19). Mercury
release due to gold mining results in envi-
ronmental contamination through direct
effluent discharge into local waterways and
through volatilization (18). Approximately
3 to 5 kg ofmercury are used to extract 1 kg
ofgold, ofwhich 25 to 45% is lost during
the amalgamation process (20).
Atmospheric mercury undergoes photo-
chemical oxidation and is then scavenged by
atmospheric particulates or precipitation.
Global contamination occurs as the mercury
is washed out ofthe atmosphere onto soil,
vegetation, andwater (4,21).
The majority of environmental MeHg
contamination has occurred through the
biotransformation ofinorganic mercury to
organic mercury (MeHg) in a process
termed methylation. During methylation,
inorganic mercury is converted into MeHg
by microbial action, primarily in sediments
of fresh and ocean waters. Methylmercury
readily enters the aquatic food chain and is
biomagnified as it accumulates in preda-
tory fish such as swordfish, pike, and ocean
tuna. Larger and more long-lived fish tend
to contain more MeHg. Methylmercury
contamination in fish can be significant;
for example, the total mercury in the edible
tissues ofshark and swordfish can average
as high as 1200 pg/kg (16). Marine mam-
mal and fish consumption, while not the
only sources of MeHg exposure, are
extremely important routes of human
exposure. This is particularly true for pop-
ulations depending on fish as a primary
food source.
Methylmercury is readily absorbed and
distributed throughout the body, including
the brain. In humans, MeHg brain levels
are approximately six times higher than
blood mercury levels (22). This is in con-
trast to rats, which have a brain-to-blood
ratio of0.06, and mice with a ratio of 1.20.
These differences in brain MeHg accumu-
lation have important implications for the
extrapolation ofhuman health guidelines
from animal data. Methylmercury also
readily crosses the placenta and appears to
accumulate in the fetus so that fetal mer-
cury levels are greater than maternal blood
mercury levels (23). The differential accu-
mulation of MeHg in the brain and the
fetus are important factors in defining
developmental MeHg neurotoxicity.
Fetal Sensitivity to
Methylmercury Exposure
Methylmercury is an excellent example ofa
known neurotoxicant that is also a preva-
lent and dangerous environmental pollu-
tant. The effects of in utero exposure to
MeHg are quite different from the effects
associated with childhood or adult expo-
sure (16). The fetus is more sensitive to
the toxic effects ofMeHg and severe effects
have been found in the offspring ofwomen
showing little or no overt evidence of
MeHg exposure (24-26). Catastrophic
exposures in both Japan and Iraq provided
evidence that mercury-exposed women
delivered infants with severe behavioral and
sensory deficits, including deafness and
blindness, without expressing significant
clinical signs or symptoms ofmercury toxi-
city during pregnancy.
On both biological and neurobehav-
ioral levels, there is strong evidence offetal
sensitivity to MeHg. Prenatal exposure to
MeHg appears to result in a widespread
pattern ofadverse effects on brain develop-
ment and organization (13,16,27-29) .
This generalized pattern ofMeHg-induced
injury to fetal brains is not seen in the
adult brain, where MeHg exposure is char-
acterized by localized lesions at specific
neural sites (30). Postmortem studies from
epidemic exposures in Japan and Iraq have
revealed that MeHg significantly alters the
normal migration of neurons to the cere-
bellar and cerebral cortices during brain
development (27,28).
Examination of the brains of infants
and animals exposed to MeHg in utero has
revealed changes in neuronal migration and
distribution patterns, cell loss (low neuronal
abundance), and reduced brain size and
gliosis (27,29,31,32). Hypotheses explain-
ing MeHg-mediated developmental neuro-
toxicity include changes in intracellular
cytoskeletal structure (33-35), oxidative
stress (36-38), alterations to membrane
function and signal transduction (39),
decreased protein production (40), and
changes in neurotransmission (41).
Neurobehavioral Effects
in Human Infants
The disruptive effects of in utero MeHg
exposure on brain development have been
associated with a broad range of neurobe-
havioral alterations in infancy and child-
hood. Published reports of studies
involving mothers and infants come pri-
marily from Japan, Iraq, Canada, and New
Zealand. There are, however, additional
reports ofmother-infant pairs under study
in the Seychelles Islands, Greenland, and
the Faroe Islands (Table 1). Methylmercury
exposure is usually estimated by blood or
hair mercury levels, and it is generally
accepted that the hair mercury concentra-
tion is 250 times that ofthe blood (16).
The catastrophic human exposures that
occurred in Minamata and Niigata, Japan
in the 1950s established that MeHg was
fetotoxic (26,42). In the Minamata Bay
study, 23 children believed to have been
exposed to MeHg in uteroshowed evidence
of mental retardation and cerebral palsy.
During pregnancy, levels of Hg exposure
were not monitored in the mothers of
these children, but as a group these women
showed little clinical evidence of MeHg
toxicity. More subtle neurobehavioral
deficits were not systematically studied in
Japan; however, a general assessment ofIQ
in elementary and junior high-school stu-
dents in the Minamata school district and
a control district did not reveal any large
differences in group performance (16). In
the city of Minamata, a separate study
found a significant correlation between
level ofMeHg in umbilical cord blood and
occurrence ofmental retardation (16).
In Iraq, an investigation of 29
mother-infant pairs was initiated after a
serious outbreak of MeHg poisoning from
consumption ofcontaminated bread (43).
Results indicated a significant relationship
between prenatal MeHg exposure and
infant psychomotor retardation. Clear evi-
dence ofdelays in attaining developmental
milestones (e.g., motor and speech retarda-
tion) were evident in children with mater-
nal hair MeHg levels less than 180 ppm.
Neurological symptoms such as increased
muscle tone and exaggerated deep tendon
reflexes were primarily associated with
maternal hair MeHg levels higher than 180
ppm. A subsequent report detailed the
results of84 mother-infant pairs (including
the 29 discussed above), with peak maternal
hair levels ranging from 0.4 to 640 ppm
(44). Severe neurological symptoms (e.g.,
blindness, deafness, failure to walk, talk, or
stand by over 4.5 years) were documented
in five children. The lowest peak maternal
hair level associated with severe neurologi-
cal problems was 165 ppm (range 165-320
ppm). These reports were the first to docu-
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Table 1. Human developmental effects of in uteroexposure to MeHg.
Geographic
location Maternal MeHg exposure Neurobehavioral effects References
Japan In Minamata, maternal samples taken 2 to 5 years Cerebral palsy, mental retardation, limb deformities, Harada (26,42)
afterfetal delivery were elevated visual disorders, delayed speech, ataxia
In Niigata, one mother had hair mercury levels of 293 ppm
during pregnancy
Iraq Severe neurological deficits, with peak hair mercury Mental and motor retardation, cerebral palsy, Marsh et al. (44)
concentrations from 165 to 320 ppm seizures, delayed speech, blindness, deafness
Mild deficits between 68 and 180 ppm
Greenland Mean blood value of 38.1 ppb Reduced birth weight Foldspang and Hansen (56)
Faroe Islands Mean cord blood of 24.2 ppb Neurobehavioral data notyet available Grandjean et al. (57)
Over25% greater than 40 ppb Grandjean and Weihe (58)
NewZealand Blood levels during pregnancy range from 6 to 86 ppb Early sensorimotor deficits such as retarded walking, Kjellstrom et al. (53)
decreased scores on developmental tests Kjellstrom etal. (54)
Canada Mean cord blood of 6 ppb; maternal hair 6 ppm Abnormal deep tendon reflex in male infants McKeown et al. (48)
ment more subtle impairments in children
exposed to lower levels of MeHg during
gestation and suggested a continuum of
MeHg-related effects closely linked to
maternal dose. Data from Iraq were reeval-
uated in an effort to determine a
dose-response relationship between mater-
nal hair levels ofmercury and developmen-
tal effects (45). From this analysis, it was
concluded that delayed onset ofwalking
may occur at maternal hair levels of 10 to
20 ppm, which is equivalent to maternal
blood mercury levels of40 to 80 ppb.
The Iraq episode provided an opportu-
nity for systematic follow-up of MeHg-
exposed infants and children (46,47).
Standard clinical and neurological tests
including the Gesell Developmental
Screening Exam were used as neurobehav-
ioral assessment measures. Offspring effects
ranged from hyperreflexia and delayed
motor activity to microcephaly, cerebral
palsy, and death. Follow-up studies at
approximately 5 years of age indicated
significant delays in psychomotor develop-
ment and persistent pathological reflexes in
a substantial number of children who did
not display clinical signs during infancy.
The clinical diagnoses of these children
resembled minimal brain dysfunction
(MBD) syndrome.
In Canada, a study ofprenatal MeHg
exposure in 234 Cree Indian infants and
children did not find strong evidence of
developmental abnormalities (48). Anthro-
pometric measurements, neurological
exams, and the Denver Developmental
Scales were used as test measures with the
children. The mean maternal hair level in
this study was 6 ppm. No effects on physi-
cal development were noted for either
males or females. Significant neurobehav-
ioral effects were limited to the finding that
maternal exposure to MeHg was related to
abnormal muscle tone (deep tendon reflex)
in male infants. No effects ofexposure to
MeHg were noted in female infants and
the authors note the questionable clinical
significance of this sex-specific finding.
Animal data, however, would suggest that
there may be sex-related effects ofprenatal
MeHg exposure, with males generally
showing a greater sensitivity to in utero
exposure (29,49-52) .
Studies ofchildren prenatally exposed
to MeHg through maternal fish consump-
tion have been conducted in New Zealand
(53). Approximately 1000 women were
identified as frequent fish consumers and
of these, 73 were identified as having
maternal hair concentrations above 6 ppm
(range 6-86 ppm). At 4 years of age, 31
offspring from this group were assessed
with the Denver Developmental Screening
Test. Evidence of a significant increase in
the risk ofearly sensorimotor dysfunction
was documented in the MeHg-exposed
group. A dose-response relationship was
established between mean maternal hair
MeHg levels and performance on the
Denver Developmental Screening Test.
A subsequent study evaluated 61 ofthe
original 73 high-dose children, at 6 to 7
years of age, on multiple assessments that
included tests of intelligence (WISC-R)
and language development (TOLD) (54).
Results showed that exposed children who
scored poorly on the Denver Develop-
mental Screening Test at 4 years of age
tended to have decreased scores on the
WISC-R intelligence test later in child-
hood. These neurobehavioral effects were
associated with maternal blood MeHg lev-
els ofonly 20 to 80 ppb.
Elevated levels of blood mercury in
women of childbearing age have been
found in polar Inuit natives in Northern
Greenland (55). The Inuits' reliance on
whale meat as a dietary mainstay is
believed to be the primary source ofexpo-
sure. Of the women tested, 84% had
blood MeHg levels that exceeded the pro-
visional limit set by the WHO (23 ppb).
As expected, the fetal levels of MeHg in
cord blood (average value of 80.2 ppb)
were higher than maternal blood levels
(average value of 38.1 ppb). An examina-
tion of the relationship between cord
blood MeHg and birth weight revealed
that decreased birth weights were associ-
ated with higher levels of fetal MeHg
exposure (56). Although information on
the neurobehavioral status of these chil-
dren is not currently available, the cord
blood MeHg levels are in the range ofval-
ues that have been associated with psy-
chomotor retardation (53).
Samples of cord blood and maternal
hair also were collected and assayed for
mercury from women living in the Faroe
Islands (57,58). With a sample size of
1000 infants, the mean mercury concentra-
tion in cord blood was 24.2 ppb, and over
25% of the samples were above 40 ppb.
This clearly exceeds the WHO provisional
limit for potential health effects and
confirms elevated in utero MeHg exposure.
Faroese children as well as the Inuit chil-
dren of Northern Greenland should be
considered at risk for neurobehavioral
alterations associated with in utero MeHg
exposure.
In summary, a review of the human
data on the developmental effects ofMeHg
exposure indicates that maternal hair levels
of 10 to 20 ppm are potentially harmful to
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fetal development. This is equivalent to
maternal blood levels of40 to 80 ppb of
mercury, assuming a mercury hair-to-
blood ratio of 250. To determine a
LOAEL, the blood mercury levels must be
converted to an estimate ofdaily consump-
tion (i.e., dose) that would result in the
equivalent blood levels. Based on kinetic
modeling ofMeHg, it is estimated that the
long-term daily consumption of 1 pg of
mercury will result in blood mercury levels
of 1 jig/liter or 1 ppb (16). Thus, the con-
sumption of 40 pg of mercury per day
would result in a blood mercury level of40
ppb; which for a 62-kg woman would be
equivalent to 0.645 pg/kg/day. Ifthe typi-
cally used uncertainty factor of 10 is used
to account for sensitive individuals (in this
case fetal development), the resulting
NOAEL or RfD would be 0.06pg/kg/day.
Neurobehavioral Effects
in Animals
As discussed above, human exposure to
MeHg during prenatal development results
in a continuum of effects ranging from
blindness, deafness, seizures, abnormal
reflexes, and retarded motor development,
to far more subtle learning, memory, and
psychological effects (5,9,25,26,47,59).
Adverse effects of MeHg exposure can
occur at human brain levels estimated to be
as low as 0.3 ppm (45).
While animal studies using high levels
of MeHg exposure have produced effects
similar to those ofhumans, there have been
few efforts to characterize the more subtle
effects oflow-dose exposure to MeHg dur-
ing development. Early effects of in utero
exposure have been documented in nonhu-
man primate infants. As part of a larger
study examining the maternal reproductive
and offspring developmental effects of
chronic exposure to MeHg, female Macaca
fascicularis monkeys were exposed to daily
doses of MeHg throughout pregnancy (0,
50, 70, or 90 pg/kg/day). Maternal blood
MeHg levels averaged 1.28, 1.62, and
2.03 ppm, respectively, for the three
treated groups. Maternal blood MeHg
levels above 1.5 ppm were associated with
a significant decrease in number ofviable
births (60).
During infancy, effects of prenatal
exposure were found on measures ofcogni-
tive and social development in the off-
spring of the MeHg-exposed monkeys. In
utero exposure to MeHg was related to
delayed attainment ofobject permanence
(61), deficits in visual recognition memory
(62,63), and abnormal social behavior
(64). These results, frequently based on
test procedures developed for use with
human infants, show that in utero exposure
to MeHg is related to delays in the attain-
ment of important cognitive milestones.
The social behavior ofthe MeHg-exposed
infants in established play groups was char-
acterized by a significant decrease in play
behavior and an increase in nonsocial
behavior. Exposed infants were less likely
to engage in species-appropriate play
behavior and spent more time alone, dis-
tancing themselves from other monkeys in
the group. In this same group ofanimals, a
latent effect ofprenatal exposure to MeHg
indicated puberal growth retardation in
exposed males (49). Exposed males exhib-
ited significantly decreased weight gain
during the juvenile stages ofgrowth (3-5
years ofage) but did catch up to the aver-
age weight ofcontrol males by early adult-
hood. Subsequent studies in adulthood
with these animals have found very slight
effects on an intermittent schedule ofrein-
forcement (fixed-interval/fixed-ratio) (65).
In this group of animals, overall study
results do not support long-term deficits in
adult learning and memory abilities (66).
However, preliminary results indicate there
may be deficits in adult visual function.
Results from this group of monkeys indi-
cate that developmental effects are seen at
maternal exposures of 50 pg/kg
MeHg/day.
Confirmation of the developmental
effects ofMeHg exposure is evident from
Canadian studies in which monkeys were
exposed to MeHg either post- or pre- and
postnatally (birth to 7 years ofage) at 25 or
50 pg/kg/day. In one study, infants were
tested on a fixed-interval operant learning
task. Exposed infants showed slight alter-
ations in performance, indicating a possible
disruption of time perception (67). In the
same study, MeHg exposure was not
related to learning impairments on dis-
crimination reversal tests. Developmental
exposure to MeHg was also shown
adversely to affect visual, auditory, and
somatosensory function in monkeys
(67-71). Visual psychophysical studies
with these monkeys have shown treate-
ment-related deficits in spatial contrast
sensitivity and facilitation of low-lumi-
nance temporal contrast sensitivity (69).
Subsequent studies have described overt
sensory-motor deficits (i.e., lack ofcoordi-
nation in exercise cages) and a loss of
vibration sensitivity (70-72). These effects
were observed at the lowest doses tested
(25 jig/kg), which is characteristic ofmany
studies with MeHg.
In rodents, one of the most frequent
findings related to prenatal MeHg expo-
sure is an increased rate of intrauterine
death (10). Studies on the developmental
effects ofMeHg on rats (Table 2) and mice
(Table 3) have provided a means ofexam-
ining specific hypotheses regarding the
mechanisms of action of MeHg. These
studies also provide information on the
levels of maternal exposure at which no
adverse effects are observed in the off-
spring. Typically, pregnant rats or mice
were dosed with MeHg for a restricted
period oftime during gestation. To com-
pensate for the short exposure periods, rela-
tively high doses ofMeHg were often used.
The most common neurological deficit
observed was altered locomotion or
exploratory behavior (73-78). These
findings are consistent with results from
high-exposure human studies which
revealed significant delays in aspects of
motor development such as crawling, stand-
ing, and walking. Learning deficits have also
been observed following developmental
exposure to MeHg (77-81).
The most comprehensive study to
assess the developmental effects ofMeHg
in rats was done as part of the
Collaborative Behavioral Teratology Study
(78). In this multilaboratory study, using
the same testing protocol, pregnant rats
were exposed to either 2 or 6 mg/kg of
MeHg on days 6 through 9 ofgestation.
These studies found dose-related changes
in behavior characterized by increased
levels of activity and impaired learning of
auditory startle habituation in exposed
pups. Lower doses of MeHg were not
examined, so a NOAEL could not be
determined. Two studies have assessed the
effects of low-level prenatal exposure to
MeHg using schedule-controlled operant
behavior (82,83). In these studies, rats
were dosed with either 0.005, 0.01, 0.05,
or 2.0 mg/kg of MeHg during days 6
through 9 ofgestation. The offspring were
then tested on a differential reinforcement
ofhigh rate schedule. This task requires the
subject to respond to a lever a specified
number of times within a fixed period to
receive a reinforcement (e.g., two responses
are required within 1 sec). No adverse
effects were observed at a dose of
0.005 mg/kg. All other treated groups had
reduced success rates. Although no blood
or brain mercury levels were reported, it is
estimated that the brain Hg levels were as
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Table 2. Effects of in uteroMeHg exposure in rats.
Dose, mg/kg Exposure Noted effects NOAEL Reference
0.005, 0.01, or 0.05 GD 6-9 Differences in DRH operant testing noted in 0.01 and 0.05 dose groups. 0.005 mg/kg dose group Bornhausen et al. (83)
0, .25, 1.25, 2.50, or 5 GD 6-15 No live offspring in 5 mg/kg dose group; 2.5 mg/kg group displayed 0.25 mg/kg dose group Geyer et al. (73)
impairment in all preweaning measures, locomotion, open field and
startle response performance; 1.25 mg/kg group showed deficits only
in swimming
0, .05, 0.5, or 5 GD 0, 7, or 14 No noted differences in litter size, birth weight, gross appearance, or 5 mg/kg dose group Hughes and Sparber (101)
operant behavior
0, .05, or 2.0 GD 6-9 Showed dose-dependent decreases in learning using the DRH operant No NOAEL Musch et al. (82)
test. No noted differences in general motility or motor coordination
0, 2 or 6 GD 6-9 Auditory startle habituation increased, increased activity measures, No NOAEL Buelke-Sam et al. (78)
alteration in visual discrimination
0 or 8 GD 8 Stereotyped sniffing elicited in treated only; no changes in locomotor No NOAEL Cuomo et al. (80)
activity, altered passive avoidance response
0, 5, or 8 GD 8 or 15 Decreased maternal weight gain at high dose, decreased neonatal No NOAEL Eccles and Annau (81,102)
activity, reduced acquisition two-way avoidance
0, 2, or 6 GD 6-9 Both dose groups showed reduced postweaning figure 8 activity, No NOAEL Vorhees (77)
increased Biel water maze time, errors and proportion of trial failures
in addition to delayed developmental growth
0, 10 (IP) GD 18 Altered brain cellulararrangement and neuronal migration No NOAEL Geelen et al. (32)
0or 5 GD 7 Altered visual-evoked potentials No NOAEL Dyer et al. (103)
0 or 2.5 Throughout Altered visual-evoked potentials No NOAEL Zenick (104)
0 or 2.5 Throughout Increased errors in waterT-maze; no motor impairment No NOAEL Zenick (105)
GD, gestational day(s).
Table 3. Effects of in uteroMeHg exposure in mice.
Dose, mg/kg Exposure Noted effects NOAEL Reference
0, 1, 2, 3, 5, or 10 GD 8 Effects noted in animals dosed 3.0 mg/kg or higher in two-way 2 mg/kg dose group Hughes and Annau (106)
shuttle box, active and passive avoidance, litter size, no motor
impairment
20, 25, or 30 GD 14, 15, or 16 Offspring at 25 and 30 mg/kg did not survive; 20 mg/kg group No NOAEL Inouye et al. (74)
showed neurologic disturbances, righting problems
0, 6, 8, or 12 GD 10 All dose groups showed decreased exploratory behavior, rearing, No NOAEL Su and Okita (75)
urination, and increased backing
0, 2, 4, or 8 GD 6-13 Retarded growth, embryolethal and teratogenic in 129 (when dosed No NOAEL Spyker and Smithberg
days 9-13), teratogenic in A/J (dosed days 9-13) (107)
0 or 8 GD 7 or 9 Decreased exploratory behavior, increased backing; demonstrated No NOAEL Spyker et al. (76)
neuromuscular impairment while swimming
GD, gestational day(s).
low as 0.04 ppm, well below levels thought
to produce adverse effects in humans.
In summary, results from monkey
studies indicate that a LOAEL for devel-
opmental effects is evident at a dose of -
25 pg/kg/day of MeHg. Rodent studies
indicate effects may be observed at doses as
low as 10 pg/kg/day ofMeHg, with effects
replicated at 50 pg/kg/day. Using the
results from the monkey studies, a NOAEL
of2.5 pg/kg/day is derived using the stan-
dard procedure ofdividing the LOAEL by
a factor of 10. To convert a NOAEL
derived from animal studies to one for
humans, an uncertainty factor of 10 is
typically used to account for interspecies
differences. An additional uncertainty factor
of 10 is then applied to account for sensitive
individuals in the human population. Using
a factor of 10 is appropriate given the sensi-
tivity ofthe developing nervous system to
the adverse effects ofMeHg. The above risk
analysis indicates that a more conservative
RfD for MeHg exposure would be 0.025
pg/kg/day, which would provide a level of
safety for thedeveloping nervous system.
Neurobehavioral Effects of
Other Neurotoxic Compounds
Methylmercury clearly is not the only com-
pound that can adversely affect the devel-
oping nervous system. Lead is one of the
best studied environmental neurotoxicants
and is a good example of the problems
associated with understanding the effects of
very low levels of exposure (84-86). The
widespread exposure of children to lead
made it possible to perform numerous
human epidemiology studies that convinc-
ingly demonstrated that low-level exposure
is harmful to the developing nervous system
(87). Animal studies, particularly those in
monkeys, confirmed that low-level expo-
sure to lead had adverse developmental
effects (88). The consequences ofthe dele-
terious effects oflead on normal childhood
development are just beginning to be
examined (85,89).
Another important widespread environ-
mental contaminant and neurotoxicant is
the lipid-soluble polychlorinated biphenyls
(PCBs). This family ofover 200 chemicals
was used primarily as insulators in electri-
cal equipment. Production of PCBs was
banned in the 1970s following recognition
of their toxicity and environmental persis-
tence. These lipid-soluble compounds are
mobilized during pregnancy, thus exposing
the infant in utero and are also readily
excreted in breast milk during lactation.
The neurotoxic effects of in utero exposure
to PCBs are well documented and have
been carefully reviewed (90-94). It is
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interesting to note that the effects ofPCBs
appeared to be more related to in utero
exposure than to postnatal exposure
through breast milk.
The voluntary consumption ofneuro-
toxic substances during pregnancy can also
result in an array of neurobehavioral
effects. Alcohol consumption during preg-
nancy produces a well-documented syn-
drome of adverse effects on the nervous
system that range from subtle deficits in
learning and memory to severe develop-
mental disorders (95-97). Animal studies
with alcohol have made important contri-
butions to the understanding offetal alco-
hol effects and demonstrate the
comparability of human and animal
findings (98). Studies on the long-term
impact of prenatal alcohol exposure
demonstrate the individual and societal
consequences ofearly neurotoxicant expo-
sure (95,97,99). Other drugs such as co-
caine also affect nervous system development
(100).
Conclusions and
Recommendations
Methylmercury is a compound worthy of
scientific and societal concern. It is clear
that MeHg is a widespread environmental
contaminant and a potent neurotoxicant
that adversely affects the developing ner-
vous system. Mercury continues to be
released into the environment by both nat-
ural and human-generated sources. It is
readily converted to MeHg and accumu-
lates in the food supply, primarily in fish
and marine mammals. MeHg is readily
absorbed and distributed throughout the
body, including the brain and the fetus.
Fetal exposure appears to be at a level that
is greater than maternal blood levels.
Studies ofhumans exposed to elevated lev-
els ofMeHg clearly demonstrate its neuro-
toxic potential. Animal studies using
rodents and nonhuman primates have
confirmed the neurotoxic potential of
MeHg. However, research into cellular and
molecular mechanisms has yet to produce
an understanding of MeHg sufficient to
allow accurate prediction ofits neurotoxic-
ity. Furthermore, human and animal stud-
ies on the neurobehavioral effects of
developmental MeHg exposure have not
determined a level ofexposure that is con-
vincingly harmless to the developing fetus.
In many ways, our understanding of
the neurotoxic potential ofMeHg is simi-
lar to that oflead 20 years ago; MeHg is a
known neurotoxicant at high levels of
exposure but there is little understanding
of its effects at lower levels of exposure.
The failure to adequately characterize the
functional effects oflow-level MeHg expo-
sure has compromised the formulation ofa
sound policy regarding the safe levels of
MeHg exposure, particularly for pregnant
women or women of child-bearing age.
Examination ofthe results ofhuman stud-
ies on the effects of MeHg indicate that
maternal hair levels of 10 to 20 ppm may
result in adverse effects on fetal outcome.
Making the appropriate assumptions and
calculations, a level of exposure not
expected to be hazardous (RfD) would be
0.06 pg/kg/day. Evaluation of results from
animal studies on the developmental effects
of MeHg provided an estimated RfD of
0.025 pg/kg/day. The human and animal
RfDs are in very good agreement.
Given the current state of knowledge
with regard to MeHg exposure, the follow-
ing recommendations are offered:
* reduce environmental release of all
forms ofmercury;
* consider restricting the global produc-
tion and sale ofmercury;
* strongly advise pregnant women and
women of child bearing age to limit
their exposure to sources ofMeHg;
* establish an RfD (reference dose) for
MeHg of0.025 to 0.06 pg/kg/day;
* continue research to determine a level
of MeHg exposure that would not
harm the developing nervous system;
* continue research to understand the
underlying molecular mechanisms of
action ofMeHg;
* assess the long-term neurodegenerative
effects of developmental MeHg
exposure.
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